Recro Pharma Announces Key Executive Promotions to the Financial Team
Jan 03, 2018 12:00 pm UTC| Business
MALVERN, Pa., Jan. 03, 2018 -- Recro Pharma, Inc. (Nasdaq:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for the hospital and other acute care settings, today announced several key...
Inventus Mining Announces Bulk Sample Results
Jan 03, 2018 12:00 pm UTC| Business
TORONTO, Jan. 03, 2018 -- Inventus Mining Corp. (TSX VENTURE:IVS) (“Inventus” or the “Company”) is pleased to announce the results from a 1,000-tonne bulk sample from the Pardo Paleoplacer Gold Project (“Pardo”) near...
Melinta Therapeutics to Present at 36th Annual J.P. Morgan Healthcare Conference
Jan 03, 2018 12:00 pm UTC| Business
NEW HAVEN, Conn., Jan. 03, 2018 -- Melinta Therapeutics (NASDAQ:MLNT), a commercial-stage company developing and commercializing novel antibiotics to treat serious bacterial infections, today announced that Dan...
Jan 03, 2018 12:00 pm UTC| Business
NEW YORK, Jan. 03, 2018 -- Tonix Pharmaceuticals Holding Corp. (Nasdaq:TNXP) (Tonix), a company developing innovative pharmaceutical and biological products to address major public health challenges, announced today...
ContraFect to Present at 10th Annual Biotech Showcase
Jan 03, 2018 12:00 pm UTC| Business
YONKERS, N.Y., Jan. 03, 2018 -- ContraFect Corporation (NASDAQ:CFRX), a biotechnology company focused on the discovery and development of protein and antibody therapeutics for life-threatening, drug-resistant infectious...
RadMax Proof-of-Concept Gas Expander Achieves Major Milestone
Jan 03, 2018 12:00 pm UTC| Business
SPOKANE, Wash., Jan. 03, 2018 -- ("REGI" or "RGUS" or "the Company") The Board of Directors, Regi U.S., Inc. and its wholly owned subsidiary, RadMax Technologies, Inc., are pleased to announce the achievement of a major...
Karyopharm Therapeutics to Present at the 36th Annual J.P. Morgan Healthcare Conference
Jan 03, 2018 12:00 pm UTC| Business
NEWTON, Mass., Jan. 03, 2018 -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a clinical-stage pharmaceutical company, today announced that Michael Kauffman, MD, PhD, Chief Executive Officer, will present at the 36th...